NASDAQ: KALAKala Bio Inc Stock Ownership - Who owns Kala Bio?
Insider buying vs selling
Have Kala Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Romulus K. Brazzell | Head of Research and Development and Chief Medical Officer | 2025-01-06 | 2,446 | $7.63 | $18.66kSell |
| Romulus K. Brazzell | Head of Research and Development and Chief Medical Officer | 2025-01-06 | 2,446 | $7.63 | $18.66kSell |
| Mary Reumuth | CHIEF FINANCIAL OFFICER | 2025-01-06 | 1,706 | $7.63 | $13.02kSell |
| Darius Kharabi | CHIEF BUSINESS OFFICER | 2025-01-06 | 2,021 | $7.63 | $15.42kSell |
| Todd Bazemore | President and Chief Operating Officer | 2025-01-06 | 1,993 | $7.63 | $15.21kSell |
| Mark T. Iwicki | CHIEF EXECUTIVE OFFICER | 2025-01-06 | 5,779 | $7.63 | $44.09kSell |
| Baker Bros Advisors LP | 10% Owner | 2024-12-30 | 30,620 | $6.44 | $197.19kBuy |
| Baker Bros Advisors LP | 10% Owner | 2024-12-30 | 279,939 | $6.44 | $1.80MBuy |
| Romulus K. Brazzell | Head of Research and Development and Chief Medical Officer | 2024-06-26 | 5,489 | $4.75 | $26.07kSell |
| Mark T. Iwicki | CHIEF EXECUTIVE OFFICER | 2024-06-26 | 15,168 | $4.75 | $72.05kSell |
KALA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when KALA insiders and whales buy or sell their stock.
KALA Shareholders
What type of owners hold Kala Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Rajeev M. Shah | 337.69% | 21,789,226 | $75.28M | Insider |
| Ra Capital Management LP | 273.30% | 17,634,380 | $60.93M | Insider |
| Gregory Grunberg | 84.49% | 5,451,860 | $18.84M | Insider |
| Orbimed Advisors LLC | 53.44% | 3,447,840 | $11.91M | Insider |
| Baker Bros Advisors LP | 18.63% | 1,201,894 | $4.15M | Institution |
| Baker Bros Advisors LP | 16.79% | 1,083,398 | $3.74M | Insider |
| Cormorant Asset Management LP | 9.35% | 603,027 | $2.08M | Institution |
| Sr One Capital Management LP | 9.28% | 598,940 | $2.07M | Institution |
| Mark T. Iwicki | 4.34% | 280,076 | $967.66k | Insider |
| Silverarc Capital Management LLC | 3.58% | 231,070 | $798.35k | Institution |
KALA vs Pharmaceutical Stocks
Kala Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.